Advanced Malignant Tumors Clinical Trials

10 recruiting

About Advanced Malignant Tumors Clinical Trials

Looking for clinical trials for Advanced Malignant Tumors? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Advanced Malignant Tumors trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Advanced Malignant Tumors clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 1

A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors

Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.96 enrolled1 locationNCT07038005
Recruiting
Phase 1Phase 2

First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors

Advanced Malignant Tumors
Shanghai JMT-Bio Inc.436 enrolled1 locationNCT06877650
Recruiting
Phase 1

A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors

Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.15 enrolled1 locationNCT07016490
Recruiting
Phase 1

A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors

Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.216 enrolled19 locationsNCT07043751
Recruiting
Phase 1

A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors

Advanced Malignant Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.30 enrolled1 locationNCT07032298
Recruiting
Phase 1Phase 2

A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd468 enrolled6 locationsNCT05779163
Recruiting
Phase 1

A Study of AK129 in Patients With Advanced Malignant Tumors

Advanced Malignant Tumors(Stage IA-IB)
Akeso182 enrolled1 locationNCT05645276
Recruiting
Phase 1

A Phase Ia/Ib Open Label,Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors

Advanced Malignant Tumors
Akeso205 enrolled1 locationNCT05868876
Recruiting
Phase 1Phase 2

A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors

Advanced Malignant Tumors
SUNHO(China)BioPharmaceutical CO., Ltd.25 enrolled1 locationNCT05991583
Recruiting
Phase 1

A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.

Advanced Malignant Tumors
NovaRock Biotherapeutics, Ltd200 enrolled1 locationNCT05877924
Recruiting
Phase 1Phase 2

A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

Advanced Malignant Tumors
SUNHO(China)BioPharmaceutical CO., Ltd.50 enrolled1 locationNCT06223841